{"count": 41, "results": [{"_id": "35592685", "pmid": 35592685, "pmcid": "PMC9113878", "title": "High-Concentration Metformin Reduces Oxidative Stress Injury and Inhibits the Growth and Migration of Clear Cell Renal Cell Carcinoma", "journal": "Comput Math Methods Med", "authors": ["Liu Y", "Li J", "Song M", "Qi G", "Meng L"], "date": "2022-05-10T00:00:00Z", "doi": "10.1155/2022/1466991", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "1466991", "score": 50274.543, "text_hl": " To explore the mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in treating @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@CCRCC@@@. ", "citations": {"NLM": "Liu Y, Li J, Song M, Qi G, Meng L. High-Concentration Metformin Reduces Oxidative Stress Injury and Inhibits the Growth and Migration of Clear Cell Renal Cell Carcinoma Comput Math Methods Med. 2022;2022():1466991. PMID: 35592685", "BibTeX": "@article{35592685, title={High-Concentration Metformin Reduces Oxidative Stress Injury and Inhibits the Growth and Migration of Clear Cell Renal Cell Carcinoma}, author={Liu Y and Li J and Song M and Qi G and Meng L}, journal={Comput Math Methods Med}, volume={2022}, pages={1466991}}"}}, {"_id": "34054309", "pmid": 34054309, "pmcid": "PMC8153069", "title": "Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib", "journal": "Cancer Manag Res", "authors": ["Fiala O", "Ostašov P", "Rozsypalová A", "Hora M", "Šorejs O", "Šustr J", "Bendová B", "Trávníček I", "Filipovský J", "Fínek J", "Büchler T"], "date": "2021-05-21T00:00:00Z", "doi": "10.2147/CMAR.S305321", "meta_date_publication": "2021", "meta_volume": "13", "meta_issue": "", "meta_pages": "4077-4086", "score": 50264.79, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use and the Outcome of Metastatic @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@Renal Cell Carcinoma@@@ Treated with @CHEMICAL_Sunitinib @CHEMICAL_MESH:D000077210 @@@Sunitinib@@@ or @CHEMICAL_pazopanib @CHEMICAL_MESH:C516667 @@@Pazopanib@@@", "citations": {"NLM": "Fiala O, Ostašov P, Rozsypalová A, Hora M, Šorejs O, Šustr J, Bendová B, Trávníček I, Filipovský J, Fínek J, Büchler T. Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib Cancer Manag Res. 2021;13():4077-4086. PMID: 34054309", "BibTeX": "@article{34054309, title={Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib}, author={Fiala O and Ostašov P and Rozsypalová A and Hora M and Šorejs O and Šustr J and Bendová B and Trávníček I and Filipovský J and Fínek J and Büchler T}, journal={Cancer Manag Res}, volume={13}, pages={4077-4086}}"}}, {"_id": "38035560", "pmid": 38035560, "pmcid": "PMC10836959", "title": "Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors", "journal": "Urol Int", "authors": ["Krebs M", "Kotlyar MJ", "Fahl J", "Janaki Raman S", "Röhrig F", "Marquardt A", "Kübler H", "Kneitz B", "Schulze A", "Kalogirou C"], "date": "2023-11-30T00:00:00Z", "doi": "10.1159/000535025", "meta_date_publication": "2023 Nov 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50262.727, "text_hl": "In specific, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ treatment caused a downregulation of @GENE_MIR21A @GENE_387140 @@@miR-21@@@ in @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@ccRCC@@@ cells. ", "citations": {"NLM": "Krebs M, Kotlyar MJ, Fahl J, Janaki Raman S, Röhrig F, Marquardt A, Kübler H, Kneitz B, Schulze A, Kalogirou C. Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors Urol Int. 2023 Nov 30;():. PMID: 38035560", "BibTeX": "@article{38035560, title={Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors}, author={Krebs M and Kotlyar MJ and Fahl J and Janaki Raman S and Röhrig F and Marquardt A and Kübler H and Kneitz B and Schulze A and Kalogirou C}, journal={Urol Int}}"}}, {"_id": "35885994", "pmid": 35885994, "pmcid": "PMC9319793", "title": "Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma", "journal": "Genes (Basel)", "authors": ["Hong SH", "Lee KS", "Hwang HJ", "Park SY", "Han WK", "Yoon YE"], "date": "2022-07-06T00:00:00Z", "doi": "10.3390/genes13071211", "meta_date_publication": "2022 Jul 6", "meta_volume": "13", "meta_issue": "7", "meta_pages": "", "score": 50260.34, "text_hl": "Synergic Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Everolimus @CHEMICAL_MESH:D000068338 @@@Everolimus@@@ on Mitochondrial Dynamics of @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@Renal Cell Carcinoma@@@", "citations": {"NLM": "Hong SH, Lee KS, Hwang HJ, Park SY, Han WK, Yoon YE. Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma Genes (Basel). 2022 Jul 6;13(7):. PMID: 35885994", "BibTeX": "@article{35885994, title={Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma}, author={Hong SH and Lee KS and Hwang HJ and Park SY and Han WK and Yoon YE}, journal={Genes (Basel)}, volume={13}, number={7}}"}}, {"_id": "37883777", "pmid": 37883777, "title": "Meta-Analysis of Metformin on Recurrence Risk and Long-Term Survival in Patients with Diabetes and Renal Cell Carcinoma.", "journal": "Altern Ther Health Med", "authors": ["Xu K", "Ying Y"], "date": "2023-10-27T00:00:00Z", "meta_date_publication": "2023 Oct 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.99, "text_hl": "Meta-Analysis of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Recurrence Risk and Long-Term Survival in Patients with @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@Diabetes and Renal Cell Carcinoma@@@.", "citations": {"NLM": "Xu K, Ying Y. Meta-Analysis of Metformin on Recurrence Risk and Long-Term Survival in Patients with Diabetes and Renal Cell Carcinoma. Altern Ther Health Med. 2023 Oct 27;():. PMID: 37883777", "BibTeX": "@article{37883777, title={Meta-Analysis of Metformin on Recurrence Risk and Long-Term Survival in Patients with Diabetes and Renal Cell Carcinoma.}, author={Xu K and Ying Y}, journal={Altern Ther Health Med}}"}}, {"_id": "33714781", "pmid": 33714781, "title": "Mechanism and application of metformin in kidney diseases: An update.", "journal": "Biomed Pharmacother", "authors": ["Song A", "Zhang C", "Meng X"], "date": "2021-06-01T00:00:00Z", "doi": "10.1016/j.biopha.2021.111454", "meta_date_publication": "2021 Jun", "meta_volume": "138", "meta_issue": "", "meta_pages": "111454", "score": 50254.953, "text_hl": "Furthermore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also contributes to the alleviation of @DISEASE_Urolithiasis @DISEASE_MESH:D052878 @@@urolithiasis@@@ and @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@renal cell carcinoma@@@ (@<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@). ", "citations": {"NLM": "Song A, Zhang C, Meng X. Mechanism and application of metformin in kidney diseases: An update. Biomed Pharmacother. 2021 Jun;138():111454. PMID: 33714781", "BibTeX": "@article{33714781, title={Mechanism and application of metformin in kidney diseases: An update.}, author={Song A and Zhang C and Meng X}, journal={Biomed Pharmacother}, volume={138}, pages={111454}}"}}, {"_id": "34548861", "pmid": 34548861, "pmcid": "PMC8434841", "title": "Effect of metformin on irinotecan-induced cell cycle arrest in colorectal cancer cell lines HCT116 and SW480", "journal": "Int J Health Sci (Qassim)", "authors": ["Khader EI", "Ismail WW", "Mhaidat NM", "Alqudah MA"], "date": "2021-09-01T00:00:00Z", "meta_date_publication": "2021 Sep-Oct", "meta_volume": "15", "meta_issue": "5", "meta_pages": "34-41", "score": 50253.867, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is widely used for the treatment of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ and found to have a crucial rule in the induction of apoptosis in several @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ types including @DISEASE_Carcinoma_Pancreatic_Ductal @DISEASE_MESH:D021441 @@@pancreatic cell carcinoma@@@, @DISEASE_Carcinoma_Ovarian_Epithelial @DISEASE_MESH:D000077216 @@@epithelial ovarian cancer@@@, @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@, and @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@renal cell carcinoma@@@. ", "citations": {"NLM": "Khader EI, Ismail WW, Mhaidat NM, Alqudah MA. Effect of metformin on irinotecan-induced cell cycle arrest in colorectal cancer cell lines HCT116 and SW480 Int J Health Sci (Qassim). 2021 Sep-Oct;15(5):34-41. PMID: 34548861", "BibTeX": "@article{34548861, title={Effect of metformin on irinotecan-induced cell cycle arrest in colorectal cancer cell lines HCT116 and SW480}, author={Khader EI and Ismail WW and Mhaidat NM and Alqudah MA}, journal={Int J Health Sci (Qassim)}, volume={15}, number={5}, pages={34-41}}"}}, {"_id": "40792151", "pmid": 40792151, "title": "Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy.", "journal": "Transl Cancer Res", "authors": ["He S", "Zhang B", "Zhang L", "Shang P", "Yue Z"], "date": "2025-07-30T00:00:00Z", "doi": "10.21037/tcr-2025-277", "meta_date_publication": "2025 Jul 30", "meta_volume": "14", "meta_issue": "7", "meta_pages": "3943-3960", "score": 50252.562, "text_hl": "Identification and validation of hub genes for @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@kidney renal clear cell carcinoma@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Everolimus @CHEMICAL_MESH:D000068338 @@@everolimus@@@ combination therapy.", "citations": {"NLM": "He S, Zhang B, Zhang L, Shang P, Yue Z. Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy. Transl Cancer Res. 2025 Jul 30;14(7):3943-3960. PMID: 40792151", "BibTeX": "@article{40792151, title={Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy.}, author={He S and Zhang B and Zhang L and Shang P and Yue Z}, journal={Transl Cancer Res}, volume={14}, number={7}, pages={3943-3960}}"}}, {"_id": "33915432", "pmid": 33915432, "title": "Metformin attenuates atherosclerosis and plaque vulnerability by upregulating KLF2-mediated autophagy in apoE-/- mice.", "journal": "Biochem Biophys Res Commun", "authors": ["Wu H", "Feng K", "Zhang C", "Zhang H", "Zhang J", "Hua Y", "Dong Z", "Zhu Y", "Yang S", "Ma C"], "date": "2021-06-11T00:00:00Z", "doi": "10.1016/j.bbrc.2021.04.029", "meta_date_publication": "2021 Jun 11", "meta_volume": "557", "meta_issue": "", "meta_pages": "334-341", "score": 50252.08, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@foam cell@@@ formation and cellular apoptosis partially through enhancing autophagy. ", "citations": {"NLM": "Wu H, Feng K, Zhang C, Zhang H, Zhang J, Hua Y, Dong Z, Zhu Y, Yang S, Ma C. Metformin attenuates atherosclerosis and plaque vulnerability by upregulating KLF2-mediated autophagy in apoE-/- mice. Biochem Biophys Res Commun. 2021 Jun 11;557():334-341. PMID: 33915432", "BibTeX": "@article{33915432, title={Metformin attenuates atherosclerosis and plaque vulnerability by upregulating KLF2-mediated autophagy in apoE-/- mice.}, author={Wu H and Feng K and Zhang C and Zhang H and Zhang J and Hua Y and Dong Z and Zhu Y and Yang S and Ma C}, journal={Biochem Biophys Res Commun}, volume={557}, pages={334-341}}"}}, {"_id": "35872697", "pmid": 35872697, "pmcid": "PMC9307380", "title": "A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes", "journal": "Dis Markers", "authors": ["Liu Y", "Meng LL", "Li JW", "Jin YS", "An RH"], "date": "2022-07-15T00:00:00Z", "doi": "10.1155/2022/7383745", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "7383745", "score": 50251.855, "text_hl": "A Randomized Study on the Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Combined with Intensive-Exercise Diet Therapy on @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@Glucose@@@ and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@ Metabolism and Islet Function in @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@Renal Cell Carcinoma@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@", "citations": {"NLM": "Liu Y, Meng LL, Li JW, Jin YS, An RH. A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes Dis Markers. 2022;2022():7383745. PMID: 35872697", "BibTeX": "@article{35872697, title={A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes}, author={Liu Y and Meng LL and Li JW and Jin YS and An RH}, journal={Dis Markers}, volume={2022}, pages={7383745}}"}}]}